Skip to main content
Top

Journal of Endocrinological Investigation

Issue 8/2008

Content (14 Articles)

Original Articles

Impact of abnormal nutrition during pregnancy on the offspring hormone resistance

W. W. Song, S. M. Zhang, H. B. Liu

Original Articles

Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia

G. Corneli, D. Vivenza, F. Prodam, G. Di Dio, A. Vottero, A. Rapa, S. Bellone, S. Bernasconi, G. Bona

Original Articles

Glycine treatment decreases proinflammatory cytokines and increases interferon-γ in patients with Type 2 diabetes

M. Cruz, C. Maldonado-Bernal, R. Mondragón-Gonzalez, R. Sanchez-Barrera, N. H. Wacher, G. Carvajal-Sandoval, J. Kumate

Original Articles

The 769G>A variant of the inhibin-α gene in Korean patients with preeclampsia

S. Y. Kim, J. H. Lim, J. H. Yang, M. Y. Kim, M. H. Kim, S. Y. Park, H. M. Ryu

Original Articles

Somatostatin analogs and gallstones: A retrospective survey on a large series of acromegalic patients

R. Attanasio, A. Mainolfi, F. Grimaldi, R. Cozzi, M. Montini, C. Carzaniga, S. Grottoli, L. Cortesi, M. Albizzi, R. M. Testa, L. Fatti, D. De Giorgio, C. Scaroni, F. Cavagnini, P. Loli, G. Pagani, E. Ghigo

Original Articles

Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism

T. Minnemann, M. Schubert, S. Freude, D. Hübler, I. Gouni-Berthold, C. Schumann, A. Christoph, M. Oettel, M. Ernst, U. Mellinger, W. Krone, F. Jockenhövel

Original Articles

Retinoic acid receptor β2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2′-deoxycytidine treatment

F. Y. Miasaki, A. Vivaldi, R. Ciampi, L. Agate, P. Collecchi, A. Capodanno, A. Pinchera, R. Elisei

Original Articles

Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study

A. Giustina, T. Mancini, P. F. Boscani, E. de Menis, E. degli Uberti, E. Ghigo, E. Martino, F. Minuto, A. Colao

Letter to the Editor

Thyroid lymphoma: Early clinical suspicion may be critical for cure

M. G. Chiofalo, G. Corazzelli, R. Franco, A. De Chiara, L. Pezzullo

Letter to the Editor

Apathetic thyrotoxicosis — Can color Doppler sonography help?

K. V. S. Hari Kumar, K. D. Modi

Letter to the Editor

A hypothesis on the death of the Greek philosopher Heraclitus

C. Fiore, D. Velo Dalbrenta, E. Ragazzi, D. Pellati, D. Armanini

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine